Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
$
0.00
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 4 Articles
Tags:
a-move-toward-evidence
,
editors-note
,
industry
,
michael-e-thase
Description
Description
Editor’s Note: The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry – Michael E. Thase, MD
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
Michael E. Thase, MD: Editor’s Letter
$
0.00
Add to cart
Details
Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
